The collective voice of the
Indian Biotechnology Sector for the past 10 years (2003-2013)
• ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology
sector and is an integral part of the national planning.
• ABLE assists in improving the operational landscape for all stakeholders.
• ABLE has over 270 members from all across India .
• Members are from all segments of Indian biotechnology: bio-pharma,
agriculture, informatics, diagnostics & devices, public institutions and
education institutions.
 ABLE serves as leading unified voice of Indian Biotechnology Sector.
 ABLE, being a part of innovation environment, articulates reports
facilitating government in framing regulatory landscape thus promoting
innovation and development.
 ABLE aims to
 Be a platform for initiating synergistic collaborations in the biotech arena among domestic players, between domestic and international firms.
 Showcase strengths of Indian biotechnology to the global audience.
 Catalyse opportunities for biotech start-ups and SMEs by linking them with
investors.
 Foster biotechnology entrepreneurship among the university student
community.
 Create ecosystem of Industry-academia and Government linkages.
To create a Vision for the Indian Biotech Industry and facilitate creation of optimal
policies with a clear and positive regulatory landscape to enable realizing the Vision
ABLE has been pro active in:
• Suggesting the setting up an Independent Biotechnology Regulatory
Authority of India(BRAI)
• Development and use of GM crops following science based methods
• Assure Intellectual Property protection that encourages Innovation
• Enable Clinical Trials to be conducted in a transparent and efficient
manner to enable development and access to safe and efficacious
medicines in a timely manner.
• Make India a global hub for fermentation based industries.
ABLE has signed MOUs with various organizations
 Biotechnology Industry Research Assistance
Council (BIRAC) to facilitate technical knowledge
& exchange information on biotech industry.
 European Business and Technology Centre (EBTC)
to foster cooperation in the biotech arena.
 Washington Biotechnology & Biomedical
Association (WBBA) for broad ranging cooperation in the field of biotechnology to support
breakthrough
discoveries
in
healthcare,
agriculture & clean energy
 NASSCOM to investigate synergies between
Biotech and IT for Healthcare and other sectors
Contd..
•
•
•
•
•
•
Indian Biotechnology - The Roadmap to the Next Decade and
Beyond
Pharma 2020 – A Bio Pharma Strategy for India
ABLE – Bio spectrum Industrial Survey
A History of Biotechnology in India
Biotech in India - Special feature on India's emerging biotech
industry
Biotechnology Industry Recommendations to DBT for the 12th
year plan
Jana
ury
February
March
April
May
June
Augus Septemb
t
er
July
20th - ABLE KBITS 4th - 6th
nd
th
11th EC 22 -25
CETAC
Bangalore
meeting Bio Chicago workshop
India BIO
on Customs
procedure
25th
Curtain
raiser
for
Bangalor
e Nano
18th
Genomics
for Crop
Improvem
ent
10th & 11th
28th
Life Science Gene
EC
Innovation Pool
meeting Northwest (Tt)
(Seattle)
11th –
ABLE
Tenth
Annivers
ary
12th BioInves
t
8th – BTFS
5th &
Monitoring th
6
Committee
AGM
Meeting
17th -21st
BIO Taiwan
EC
meeting
(Tt)
11th –
13th BIO
Korea
2013
Appraisal
for ABLE
staffs
October
November
18th – 21st
and 25th –
28th
6th -9th
Stimulation
BEST India
bio2013
Entrepreneur
Talk
21st – 23rd
India Lab
Expo
(Hyderaba
d
Decembe
r
NEST
22nd, 23rd,
24th
Nascent
Gene
Entrepreneur Pool(Tt)
Development
Programme
BIO INVEST
22nd –
24th
NEST
EC
meeting
(Tt)
Bangalor
e Nano
(Tt)=Tentative
* Highlighted blocks represents Flagship events
 Dr. Anil Ram Chauhan,
Director
 Mr. Purushotam M Chandra,
Liaison Officer
 Mr.S.K.Raghu, Assistant ManagerAdmin
 Mr. Amitesh Suman,
Sr. Manager-Business
Development& Operations
 Ms.Brinda Rajendran,
Sr. Executive - Business Development &
Operations
 Ms. Priyanka Nathan, Executive
-Operations
Association of Biotechnology Led Enterprises – ABLE
Bangalore:123/C, 16th Main Road,5th Cross, 4th Block, Koramangala, Bangalore – 560 034 India
Telephone: +91-80-4163 6853 / 2563 3853, Telefax:+91-80-2563 3853
New Delhi:12-A-II, Vandana Building, 12th Floor, 11-Tolstoy Marg, New Delhi – 110 001 India
Telefax: +91-11-2373 1127
Website: www.ableindia.in
Email: info@ableindia.org
•
•
•
•
•
CL
IP
Clinical trials
Biosimilars
Other national issues
•
•
•
•
GDP – Biotechnology contributes 0.2% of the total GDP
India ranks among top 12 destinations for Biotech
worldwide and 3rd in the Asia-Pacific region
Over past 5 yrs invest made in Indian Healthcare and
Life Sciences space sums to 1million dollar.
Additional 2 billion USD is expected to be invested in to
this space as per The Venture Intelligence survey of
leading Private Equity (including Venture Capital)
Spending on R&D in India
12.2%
300 Universities/ Colleges
500,000 students/year
Allocation of Budget to DBT
BIOTECHNOLOGY CLUSTER IN INDIA
BIOTECHNOLOGY CLUSTER & INCUBATION CENTRE IN
INDIA
CONTENTS
1. FOREWORD
2. HISTORY -THE JOURNEY THUS FAR
3. BIOTECHNOLOGY ENABLERS - Industry, R& D Giants, Health of the Nation
4. BIOTECH PEOPLE-DARING ENTREPRENEURS
5. BIOTECH COMPANIES IN INDIA - Market dynamics, Market size, Market potential,
Investment, R & D Expenditures
6. BIOTECH INSTITUTIONS - Facilities, Faculty, Expansion, Incubation
7. BIOTECH INNOVATIONS - Innovations in GM crops, Molecular diagnostics, Vaccines
8. BIOCLUSTERS & FUTURE OF BIOTECH - International institutional investment,
Foreign direct investment, merger & acquisition, collaboration
9. ACKNOWLEDGEMENTS
10. GLOSSARY
• STUDENT
• To understand opportunities available for industrial training , On Job
training Opportunity, Entrepreneurial skill development programme,
connect to ABLE flagship events – BEST & NEST, Webinars.
• Connect to various public sector grants and projects through DBT, BIRAC
and DST etc.
• Opportunity to attend conferences and seminars for skill development
and industrial exposure.
• Opportunity to find access to funds and investment for young startups.
• Support through incubation centre and cell both in universities and
knowledge parks.
• Networking with industry leaders and VC group to attract investment for
growth and funding.
• Our large network of database of universities and student to share and
connect for knowledge sharing and exploring joint collaboration for
various innovative projects in India and abroad.
Indian Biotech companies/International Trade commission
•
•
•
•
•
•
•
•
•
•
•
ABLE acts as a single point of reference for comprehensive information relevant to the Indian Biotech
industry.
ABLE creates and ecosystem of bio-economy to bring industry academia and government together to address
issues related to growth of Biotech.
ABLE’s sector specific focused committee brings in direct agenda in public sector domain to find and discuss
policy issues .
ABLE’s B2B network helps our service provider companies to network and showcase strength relevant to
target companies.
ABLE works closely with the Government to highlight and address issues affecting the Sector.
ABLE generates access to policies of the Indian government towards Biotechnology, including transitory
changes in the regulatory and patenting framework.
ABLE brings out sector specific reports that provide inputs on industry trends and technologies.
ABLE allows members to form their focused committee to formulate their own charter under democratically
selected chairman and drive their industry specific agenda for creating growth.
ABLE organises conferences and other networking events which allow members to interact with policy
makers, industry leaders and eminent academicians.
ABLE allows members special privileges and preferred participation in seminars, conferences, exhibitions and
other Biotechnology-related activities conducted by itself and its Associates in India and abroad.
Great platform for international companies to connect and explore collaboration opportunities in both
business and R&D. Similarly Indian companies to go global to explore international market and finding
licensing opportunities.
Category
Sub-category
ABLE Membership Fee
Joining Fee
Membership by
Invitation
Patron 5,00,000
12,500
Affiliate 2,00,000
10,000
Sustaining 25,000
Ordinary
Membership
Associate
Membership
Ancillary &
Supporting
Fees
Individual
Members
NGO
Patron/Affiliate
/Sustaining
Annual Fee
12,500
Companies that are Start-ups 3,750
3,750
Companies with <5crores turnover 7,500
7,500
Companies with 5-50 crores 11,250
11,250
Companies with 50-100 crore 18,750
22,500
Companies with >100 crores 18,750
31,250
Government, Funded R & D, Academic Institutions Nil
Private R & D, Academic Institutions 3,125
Service Providers - Indian Nil
Banks & Financial Institutions - Indian 12,500
Indian Student Nil
Nil
-12,500
12,500
250
Indian Professional Nil
2,500
Indian NGO Nil
3,125
Patron Nil
Affiliate 2,00,000
Sustaining 25,000
12,500
12,500
10,000
THANKS